Lv5
1048 积分 2023-10-07 加入
Astragaloside IV Binds with RhoA, Inhibits EndMT and Ameliorates Myocardial Fibrosis in Mice
4个月前
已完结
Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling
4个月前
已完结
Osteoporosis remission via an anti-inflammaging effect by icariin activated autophagy
10个月前
已完结
Pathological mechanisms of kidney disease in ageing
10个月前
已完结
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
11个月前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
11个月前
已完结
Advances and challenges in kidney fibrosis therapeutics
1年前
已完结
GPCR drug discovery: new agents, targets and indications
1年前
已完结
Fibrosis: cross-organ biology and pathways to development of innovative drugs
1年前
已完结
皖公网安备34019202002308
